CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis - Wikidata - awgldk - TriplyDB

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

http://www.wikidata.org/entity/Q33882408

about

New treatment options for alcoholic hepatitis Inflammatory status in human hepatic cirrhosis Alcoholic Liver Disease: Role of Cytokines The immunogenetics of primary biliary cirrhosis: A comprehensive review Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?Hepatic inflammation and fibrosis: functional links and key pathways.Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis.Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis Age-related sensitivity to endotoxin-induced liver inflammation: Implication of inflammasome/IL-1β for steatohepatitis.Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.Immune dysfunction in acute alcoholic hepatitis.Suppression of FoxO6 by lipopolysaccharide in aged rat liver.Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse model.Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease LPS-TLR4 Pathway Mediates Ductular Cell Expansion in Alcoholic Hepatitis Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment.Immunology in the liver--from homeostasis to disease.Alcoholic hepatitis: Translational approaches to develop targeted therapies.Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.Targeting inflammation for the treatment of alcoholic liver disease.Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury.Systemic Inflammatory Response Syndrome in Acute on Chronic Liver Failure- Relevance of 'Golden Window'- a Prospective Study.The proton-sensing G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) shows cardioprotective effects against myocardial infarction.Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury.Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes.Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.Lipopolysaccharide induces the differentiation of hepatic progenitor cells into myofibroblasts via activation of the Hedgehog signaling pathway.The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.Characterization of structural and immunological properties of a fusion protein between flagellin from Salmonella and lumazine synthase from Brucella.A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis.NBAS mutations cause a multisystem disorder involving bone, connective tissue, liver, immune system, and retina.CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.Transcriptomic Profiling of Obesity-Related Nonalcoholic Steatohepatitis Reveals a Core Set of Fibrosis-Specific Genes.Synbiotics Bifidobacterium infantis and milk oligosaccharides are effective in reversing cancer-prone nonalcoholic steatohepatitis using western diet-fed FXR knockout mouse models

P2860

Q26751402-B4FD992B-A111-41FB-85E0-084A7185258F Q26778040-EA85E43C-7B89-445E-B3D8-84E326C57D32 Q26783558-3E79B103-63B1-4991-B875-14E07A02F9E9 Q26801377-A56928E5-A4FD-4E71-8510-45DCA58ED3CC Q27025680-3FC0CA0E-291E-48F7-BEB5-5C28D5F05096 Q33746502-2604731C-8CDC-4F7D-964B-8EB3C0F61CAB Q35213917-C1648CA5-C6E7-46F2-9313-EF22BF67C4DF Q35256601-6A45AF15-A426-4956-B07D-56A96EEDCB88 Q35874927-9574A39E-CC56-4D31-86CD-5C299CC8A515 Q35915822-104F25E7-8169-4938-8198-E28D8FC3A823 Q35935130-2F5CFEA3-11FE-4BC4-AEE8-E77BAADD8F94 Q35995445-22E51CDD-AA16-439D-AA7E-40779B3A3755 Q36269642-FC9B75B1-104E-4C5A-90ED-B70729D671C8 Q36544036-BF2D68FB-3D28-416A-81B3-455E1A3710C1 Q36693626-2EB1F40F-FC45-4AA8-A2D5-58C66EEC903C Q37057228-ADA27049-8491-44F7-92B6-C4A2773AE0F5 Q37345576-C96BA527-ED56-40B4-BA8C-4C0244CAD9E3 Q38677715-1CA17D07-CE96-42D6-9AB6-893F2C80584D Q38693925-D8E5A5D8-EB25-4D83-BD32-8D59D2D7971A Q38759707-E27119B8-3044-48AC-B2C2-DFC50BBA6363 Q38806840-40053543-C3FB-45BF-8F82-95AD21B21818 Q39376604-14FE5D69-8B39-4F89-BD0A-C6CB38B8F5D7 Q39392481-90B8B5F5-AF32-411C-B595-25A0EB0986E6 Q40245731-9F8F3232-5EB3-4747-828E-4AF8B329FBCB Q40265784-23C846FB-F8EF-4AE7-B814-5855ECB65A89 Q41352801-28E0F5AD-16B1-44FC-8248-1838807DA023 Q41480019-D5C9562C-4274-4872-BC11-F06F4D204C1E Q41786318-F1A8D546-A69F-4978-AD20-B908B79045D9 Q42695159-F378948A-A5BF-49F3-9123-60DB74EBA379 Q45868380-0D36DD0D-710C-45B9-8F16-FA04B663DA0A Q46069086-099CE6B3-B1E6-4061-A4C9-5A2F40ABCF4D Q47379248-43A8CE0D-0506-4FE1-8128-864CE83E6CF4 Q49954533-0D1091B3-C805-4D24-ACD6-C625A8504C71 Q50218188-AA828C3F-B825-4902-B3E1-26AD60286F90 Q52923556-A51B189F-04C3-4738-B004-93BF57B88671 Q55024109-1AFB757F-0A65-457C-BCD6-9F0066EDE9E1 Q55442577-406DE360-5922-427B-8925-89045C3AE999 Q57115983-9CE5A3E1-AC67-4644-AA11-787ADD4A6DAB

P2860

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

http://www.wikidata.org/entity/Q33882408

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@ast

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@en

type

label

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@ast

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@en

prefLabel

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@ast

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@en

P1433

Q33882408-C30817D1-D139-4C46-9433-EC49A2EA5983

P1476

Q33882408-6CB8B58B-99CE-4056-9427-DBDF62F57EE4

P2093

Q33882408-005017B2-919F-4192-A637-F316AF511F8B

Q33882408-0A438A03-2C94-4605-8F7C-DAA30E39EFA6

Q33882408-22E4D43C-9D5C-40AC-B82D-7DD59E9B1D00

Q33882408-2C24B904-4AA5-45E5-97FC-9180E9663FF4

Q33882408-3A4F9752-0635-4C21-8245-2F6F7BDBD2E9

Q33882408-4EF0BFFE-4409-479D-9CDE-DC48F8C9790A

Q33882408-CD8EB8DA-76FB-47BD-9B4C-40681203DBA5

Q33882408-DA0E9F7E-6678-4156-B9EC-5D10E7BF8D8D

Q33882408-EF26568E-830A-4353-BDE7-A9F393A34B39

P2860

Q33882408-0747EB4B-E858-43C2-88E6-17768B45AC08

Q33882408-07A660DE-D7DA-48A7-955F-0ED2F719BBA2

Q33882408-0B6FCAA1-80D2-4396-B5E2-E2DBB87983AF

Q33882408-0D8C8482-9023-43FF-B3C3-D7C5712CBF9A

Q33882408-2494F859-B0BB-4F7C-90B6-966CA7180F35

Q33882408-2C85D622-EC63-4678-B88B-19CF2B4DC166

Q33882408-2CB2D0BF-4AA4-462F-9603-23A0182F65FA

Q33882408-316677EE-1859-4411-9356-13AD620C2C1E

Q33882408-35223303-5F5A-45AF-8EDC-E6E51A0CD9EF

Q33882408-3D049119-58AC-4314-B363-F8613066D24F

P304

Q33882408-B3E09B7D-E8FC-4488-9812-AEECD071C10F

P31

Q33882408-91521AA0-BBF8-445E-99E2-A6D3A297E24A

P356

Q33882408-A6B0C1E1-713F-4371-BC2C-974568DF77F4

P407

Q33882408-B1A642F5-30A5-4A29-ABDB-2A71437E5D72

P433

Q33882408-3747CC6D-E215-42F2-89BB-FA6BFD2EE4B1

P478

Q33882408-6469249F-91D6-4B52-BABB-EF7D195A9D35

P50

Q33882408-0EECE3EA-AC31-4D64-BBC6-CF55EA1C5DB7

Q33882408-452E1F12-B692-45F6-9FD5-41A4C4ABCD7B

Q33882408-803CC66A-9222-42D6-AD53-DADD9DA520D5

Q33882408-A298A217-C173-40A4-B4AF-A1DE4DD71487

Q33882408-BF73B0A4-5A41-4A1C-9983-E1A72A8D4A53

Q33882408-DB56E554-AE9F-4547-88E3-64735D13560A

P577

Q33882408-ABCF3911-E2CE-49F5-8969-FEE609F50737

P698

Q33882408-89EF7761-A5FF-49EB-917D-D8845E908722

P921

Q33882408-ACBA656D-540A-475B-A188-FEF31C09DFFE

P932

Q33882408-3F07E58D-C3B8-4DCE-B8B0-4D60E9B8C211

P356

GUTJNL-2013-306098

P1433

P1476

CCL20 mediates lipopolysacchar ...... ibrosis in alcoholic hepatitis

@en

P2093

Cristina Millán

http://www.w3.org/2001/XMLSchema#string

Daniel Rodrigo-Torres

http://www.w3.org/2001/XMLSchema#string

Delia Blaya

http://www.w3.org/2001/XMLSchema#string

Dianne H Dapito

http://www.w3.org/2001/XMLSchema#string

Jorge M Caviglia

http://www.w3.org/2001/XMLSchema#string

José Altamirano

http://www.w3.org/2001/XMLSchema#string

Juan Caballería

http://www.w3.org/2001/XMLSchema#string

Oriol Morales-Ibanez

http://www.w3.org/2001/XMLSchema#string

Robert F Schwabe

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2

Alcoholic liver disease: pathogenesis and new therapeutic targets.

Alternative activation of macrophages

Chemokines--chemotactic cytokines that mediate inflammation

TLR4 enhances TGF-beta signaling and hepatic fibrosis

The CC chemokine CCL20 and its receptor CCR6.

Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis.

Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.

Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.

Toll-like receptors in the pathogenesis of alcoholic liver disease.

P304

1782-1792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUTJNL-2013-306098

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24415562

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

4092046

http://www.w3.org/2001/XMLSchema#string